P77 Neutralising antibody responses against SARS-CoV-2 Omicron BA.4/5 and wild-type strain in patients with IBD after three doses of COVID-19 vaccine

Zhigang Liu,James Goodhand,Hajir Ibraheim,Claire Bewshea,Kaixing Le,Nick Powell,Sulakchanan Anandabaskaran,Tariq Ahmad,Ailsa Hart,Laura Constable,Aamir Saifuddin,Xin Zhou,James L Alexander ,Sebastian Scheer ,Katrina M Pollock ,Charlie W Lees ,G R Jones ,Rosemary J Boyton ,Peter Irving ,Nicholas A Kennedy

doi:10.1136/gutjnl-2023-bsg.149

P77 Neutralising antibody responses against SARS-CoV-2 Omicron BA.4/5 and wild-type strain in patients with IBD after three doses of COVID-19 vaccine

Zhigang Liu, James Goodhand + Show 18 more

https://doi.org/10.1136/gutjnl-2023-bsg.149

Copy DOI

Journal: Gut

Publication Date: Jun 1, 2023

Affiliation: Royal Devon & Exeter NHS Foundation Trust, Imperial College London, University of Hull, University of Edinburgh, King's College London

#Doses Of Vaccine #Inflammatory Bowel Disease + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

IntroductionPatients with Inflammatory bowel disease (IBD) receiving anti-TNF or JAK-inhibitor therapy have attenuated responses to COVID-19 vaccination. We aimed to determine how IBD treatments affect neutralising antibody responses against Omicron...

Full Text